Related Experiment Video

Updated: May 2, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

[Pneumococcal meningitis in children]

Š Rumlarová1, P Kosina, R Kračmarová

  • 1Department of Infectious Diseases, Faculty of Medicine, University Hospital, Hradec Králové Czech Republic,

Klinicka Mikrobiologie a Infekcni Lekarstvi
|March 14, 2014
PubMed

Insights

Pneumococcal meningitis in children remains a serious threat, with nearly 30% experiencing permanent damage, primarily hearing impairment. Vaccination is crucial for prevention, especially in infants and at-risk children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Invasive pneumococcal diseases, particularly pneumococcal meningitis, pose significant risks to pediatric populations.
  • Effective management and prevention strategies are critical for improving outcomes in children with this serious infection.

Purpose of the Study:

  • To present the clinical experiences and treatment outcomes of pediatric inpatients with pneumococcal meningitis.
  • To analyze the characteristics, complications, and long-term sequelae of pneumococcal meningitis in children over a 10-year period.

Main Methods:

  • Retrospective assessment of pediatric patients (0-18 years) hospitalized between 2002-2011.
  • Analysis of clinical data, including age, predisposing factors, complications, and treatment outcomes.
  • Cerebrospinal fluid (CSF) analysis, including culture and PCR for Streptococcus pneumoniae detection.

Main Results:

  • Twenty-seven children with pneumococcal meningitis were treated; 63% were under 2 years old.
  • Intracranial complications occurred in 10 cases, and 40% had concurrent middle ear or sinus infections.
  • No deaths were reported, but 29% of patients suffered permanent damage, predominantly hearing impairment (7 cases).

Conclusions:

  • Pneumococcal meningitis remains a severe pediatric condition with a risk of significant long-term consequences.
  • Vaccination is emphasized as a primary preventive measure, particularly for infants and children with predisposing factors.
  • Continued vigilance and prompt treatment are essential for managing invasive pneumococcal disease in children.
Abstract

More Related Videos

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/4306:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K
Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae09:12

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

Published on: January 17, 2014

12.2K

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K